<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Retraso Diagnóstico en Oncología Pediátrica

cic.institucionOrigenInstituto de Desarrollo e Investigaciones Pediátricas "Profesor Dr. Fernando VITERI"es
cic.isFulltexttruees
cic.isPeerReviewedtruees
cic.lugarDesarrolloInstituto de Desarrollo e Investigaciones Pediátricas "Profesor Dr. Fernando VITERI"es
cic.lugarDesarrolloHospital Interzonal de Agudos Especializado en Pediatría "Sor María Ludovica"es
cic.parentTypeArticulo
cic.versioninfo:eu-repo/semantics/publishedVersiones
dc.date.accessioned2016-07-14T16:31:12Z
dc.date.available2016-07-14T16:31:12Z
dc.identifier.urihttps://digital.cic.gba.gob.ar/handle/11746/3051
dc.titleRetraso Diagnóstico en Oncología Pediátricaes
dc.typeArtículoes
dcterms.abstractWe retrospectively reviewed the charts of 550 patients of less than 19 years of age with cyto-histological diagnosis of malignancy, admitted from January 1979 to December2000. Retrieved data included: time from the beginning of symptoms to first consultation (family delay), time from first medical consultation to reference to the specialized Centre (with or without diagnosis of tumor disease) (Medical delay) and time from admission at the Reference Centre to diagnosis (Reference Centre delay). Of the grand total of 550 patients 204 (36%) belonged to group A (1979-89) and 346 (64%) to group B (1990-2000). Of these, 189 (92.5%) of group A and 342 (98.5%) of group B (n:531) were adequate for evaluation. Nineteen patients (3.4%) were excluded due to incomplete data (8 patients), no follow-up, or referral to another center after diagnosis (11 patients). As grand total from this series it is clear that those patients with early diagnosis (less than 30 days) had a high survival (83.5%), while this number decreased with longer delays (53.3% in 30-60 days and 30.8% in longer than 90 days), but the period of follow-up of Group A (1979-1989) was longer. At the same it was noticed that the survival increased when both periods were compared (1979-89 vs. 1990-2000) from 54.8% to 72.8%, even with no significant changes in the diagnostic delay. This observation sustains the fact that therapeutic advances may disregard the delays. Anyway, delay in diagnosis determines metabolic and nutritional changes, and progression of the disease all of which prevent the use of aggressive and short therapeutic protocols. So, poor response to chemotherapy is more frequent in patients with advanced stages of disease. These patients also present more regularly infectious complications and malnutrition which result in poor tolerance to the treatment.en
dcterms.alternativeDelayed diagnosis in pediatric oncology. An experience with 550 patients at a pediatric hospital (1980-2000)en
dcterms.creator.authorPollono, Daniel G.es
dcterms.creator.authorTomarchio, Silviaes
dcterms.creator.authorAstudillo, Lucianoes
dcterms.creator.authorPardini, Gabrielaes
dcterms.creator.authorArmendariz, Federicoes
dcterms.creator.authorLancioni, Eduardoes
dcterms.creator.authorPollono, Agustinaes
dcterms.extentp. 5-28es
dcterms.identifier.otherISSN 1514-5654es
dcterms.isPartOf.issuevol. IX, nº 1es
dcterms.isPartOf.seriesLudovica Pediátricaes
dcterms.issued2007-03
dcterms.languageEspañoles
dcterms.licenseAttribution 4.0 International (BY 4.0)es
dcterms.subjectcáncer pediátricoes
dcterms.subjectretraso diagnósticoes
dcterms.subjectSobrevidaes
dcterms.subject.materiaPediatríaes
dcterms.title.subtitleA propósito de 550 observaciones en un Hospital Pediátrico (1980-2000)es

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
5_PDFsam_2007_1.pdf-PDFA.pdf
Size:
194 KB
Format:
Adobe Portable Document Format
Description:
Documento completo